F Mantero Selected Research

F Mantero Research Topics

Disease

13	Hypertension (High Blood Pressure) 12/2007 - 01/2000
11	Adenoma (Adenomas) 03/2013 - 01/2000
10	Neoplasms (Cancer) 06/2011 - 01/2000
7	Cushing Syndrome 02/2014 - 02/2000
7	Hyperaldosteronism (Conn Syndrome) 03/2012 - 02/2000
5	Pheochromocytoma 06/2011 - 02/2000
5	Insulin Resistance 05/2011 - 06/2000
4	Essential Hypertension 01/2003 - 02/2000
4	Carcinoma (Carcinomatosis) 11/2001 - 01/2000
3	Acromegaly 05/2011 - 07/2008
3	Pituitary Neoplasms (Pituitary Adenoma) 12/2010 - 07/2007
3	Hyperplasia 07/2008 - 02/2003
3	Hypokalemia 03/2007 - 02/2000
3	Obesity 03/2007 - 06/2000
3	Infertility (Sterility) 07/2003 - 09/2001
2	Pituitary ACTH Hypersecretion 04/2014 - 01/2011
2	Adrenocortical Carcinoma 12/2013 - 06/2011
2	Prolactinoma (Prolactinomas) 09/2010 - 07/2007
2	Amenorrhea 12/2007 - 01/2005
2	Congenital adrenal hyperplasia due to 21 hydroxylase deficiency 03/2007 - 02/2003
2	Varicocele 01/2004 - 04/2002
2	Adrenocortical Adenoma (Disease, Conn's) 11/2001 - 01/2000
1	Thrombophilia 02/2014
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2014
1	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 04/2012
1	Adrenal incidentaloma 06/2011
1	Adrenal Gland Neoplasms (Adrenal Cancer) 05/2011
1	Familial Isolated Pituitary Adenoma 09/2010
1	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 09/2010
1	Hypopituitarism (Sheehan's Syndrome) 09/2008
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 09/2008
1	Acth-Independent Macronodular Adrenal Hyperplasia 12/2007
1	Hirsutism 12/2007
1	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 03/2007
1	Brain Neoplasms (Brain Tumor) 06/2006

Drug/Important Bio-Agent (IBA)

11	Hydrocortisone (Cortisol)FDA LinkGeneric 07/2011 - 02/2000
8	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2011 - 02/2000
7	AldosteroneIBA 03/2013 - 02/2000
5	Glucose (Dextrose)FDA LinkGeneric 05/2011 - 06/2000
5	MineralocorticoidsIBA 03/2007 - 08/2000
4	Messenger RNA (mRNA)IBA 06/2011 - 06/2000
4	Insulin-Like Growth Factor I (IGF-1)IBA 05/2011 - 06/2006
4	AndrogensIBA 09/2008 - 10/2000
4	SaltsIBA 11/2000 - 01/2000
3	ReninIBA 03/2012 - 06/2000
3	Hormones (Hormone)IBA 06/2011 - 09/2000
3	methylamphotericin B (AME)IBA 06/2011 - 08/2000
3	aryl hydrocarbon receptor-interacting proteinIBA 05/2011 - 09/2010
3	Insulin (Novolin)FDA Link 05/2011 - 01/2005
3	GlucocorticoidsIBA 01/2011 - 02/2003
3	Cortisone FDA Link 12/2003 - 11/2000
3	11-beta-Hydroxysteroid Dehydrogenases (11beta Hydroxysteroid Dehydrogenase)IBA 01/2001 - 08/2000
2	Mitotane (Lysodren)FDA Link 12/2013 - 01/2009
2	Dexamethasone (Maxidex)FDA LinkGeneric 06/2011 - 02/2000
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 06/2011 - 03/2009
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 03/2011 - 12/2007
2	DNA (Deoxyribonucleic Acid)IBA 09/2010 - 01/2000
2	Proteins (Proteins, Gene)FDA Link 01/2009 - 01/2000
2	Estrogens (Estrogen)FDA Link 03/2007 - 04/2001
2	LipidsIBA 01/2006 - 01/2005
2	Triglycerides (Triacylglycerol)IBA 01/2006 - 01/2005
2	Spironolactone (Aldactone)FDA LinkGeneric 01/2005 - 02/2000
2	laurdanIBA 07/2003 - 09/2001
2	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2001 - 01/2000
2	IsoenzymesIBA 11/2000 - 08/2000
2	AngiotensinogenIBA 06/2000 - 06/2000
1	Cabergoline FDA LinkGeneric 04/2014
1	Ketoconazole (Nizoral)FDA LinkGeneric 04/2014
1	Thrombin FDA Link 02/2014
1	AnticoagulantsIBA 02/2014
1	SeleniumIBA 04/2012
1	gastric inhibitory polypeptide receptorIBA 07/2011
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2011
1	pasireotideIBA 06/2011
1	somatostatin receptor type 1IBA 06/2011
1	Somatostatin Receptors (Somatostatin Receptor)IBA 06/2011
1	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 03/2011
1	ProlactinIBA 09/2010
1	lanreotide (Somatuline)FDA Link 03/2009
1	Cisplatin (Platino)FDA LinkGeneric 01/2009
1	AntibodiesIBA 01/2009
1	Tyrosine Kinase InhibitorsIBA 01/2009
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 01/2009
1	Etoposide (VP 16)FDA LinkGeneric 01/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2009
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 01/2009
1	Streptozocin (Streptozotocin)FDA Link 01/2009
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2009
1	LH Receptors (LH Receptor)IBA 12/2007
1	PPAR gammaIBA 07/2007
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 07/2007
1	LigandsIBA 07/2007
1	ThiazolidinedionesIBA 07/2007
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 03/2007
1	Arginine (L-Arginine)FDA Link 06/2006

Therapy/Procedure

8	Therapeutics 04/2014 - 02/2000
7	Adrenalectomy 06/2011 - 02/2000
1	Injections 03/2009
1	Drug Therapy (Chemotherapy) 01/2009
1	Estrogen Replacement Therapy 09/2008